Header image

Concurrent Session 6B - Part 1: Assessment and Outcome Measures | Part 2: Opioid Replacement

Tracks
Track 2
Friday, November 1, 2024
1:10 PM - 2:40 PM
Bradman

Details

Chair: Kate Senior, DASSA


Speaker

Agenda Item Image
Dr Matthew Stevens
Senior Research Fellow
The University of Adelaide

Evaluation of psychometric properties and performance of the ASSIST-Y in assessing risk of substance-related harm and dependence among male adolescents in juvenile detention.

1:10 PM - 1:15 PM

Biography

Matthew Stevens is a Senior Research Fellow and Early Career Researcher at the University of Adelaide. Dr Stevens' research focuses on prevention and early intervention approaches for substance-based and behavioural addictions.
Dr Claire Garnett
Research Fellow
University of Bristol

The effect of question order on outcomes in the ORBITAL core outcome set for alcohol brief interventions among online help-seekers

1:15 PM - 1:20 PM

Biography

Dr Claire Garnett is a NIHR Advanced Fellow at the University of Bristol (UK) in the Tobacco and Alcohol Research Group. Her research focuses on alcohol harm reduction, the role of digital technologies to support behaviour change, and the population level influences on alcohol consumption and smoking.
Agenda Item Image
Miss Emma Hatton
Phd Candidate
University of Wollongong

Change sensitivity and correlates of change on a measure of recovery following discharge from residential rehabilitation

1:20 PM - 1:25 PM

Biography

Emma is a PhD Candidate, Research Assistant and Casual Academic at UOW working in AOD research for the past 5 years. During this time she has worked across multiple randomised controlled trials, measure validation studies, and systematic reviews. Her current research focus is outcomes and effectiveness for residential rehabilitation.
APSAD 2024

Session Q&A

1:25 PM - 1:30 PM

Biography

Dr Chris Tremonti
Staff Specialist
St Vincent's, Sydney

Micro-dosing versus standard transfer for methadone-buprenorphine transfers - results from an open-label, non-randomised clinical trial

1:30 PM - 1:40 PM

Biography

Dr Tremonti is an addiction specialist and clinical pharmacologist working at St Vincent's Hospital in Sydney, and undertaking his PhD with Sydney University on the long term health outcomes of opioid treatment programs. He has published on QT prolongation in opioid treatment, nitrous oxide risks and clinical drug testing.
Dr Stacey Weedon
Staff Specialist
Hunter New England Local Health District

The opioid covid risk assessment project: A study of opioid agonist treatment in a public outpatient service in New South Wales, Australia before and after COVID-19 related changes

1:40 PM - 1:45 PM

Biography

Stacey is a Staff Specialist in Addiction Medicine with the Hunter New England Local Health District. She has a has a Fellowship of the RACP in General and Acute Care Medicine and is nearing completion of her Fellowship in the Chapter of Addiction Medicine.
Dr Natasha Hall
Research Fellow
Eastern Health

Does the location of opioid agonist treatment prescribers and dispensers impact the number of opioid-related ambulance attendances?

1:45 PM - 1:55 PM

Biography

Natasha is a research fellow at Turning Point and the school of public health at Monash University. She completed her PhD in 2024, which aimed to determine the societal economic burden associated with opioid use disorders in Australia and identified treatment barriers for those experiencing opioid use disorders.
Professor Nicholas Lintzeris
Senior Staff Specialist
SESLHD

Withdrawing from long-acting injectable buprenorphine treatment – what does the withdrawal syndrome look like.

1:55 PM - 2:05 PM

Biography

Nicholas is an addiction medicine specialist and researcher with 35 years of experience in AOD sector. He has been involved in medicinal cannabis developments for over 10 years in Australia, and has led a number of clinical trials for the treatment of CUD.
Dr Llewellyn Mills
Senior Research Associate
Specialty of Addiction Medicine, University of Sydney

Withdrawing from long-acting injectable buprenorphine treatment – what does the withdrawal syndrome look like.

1:55 PM - 2:05 PM

Biography

Dr Llew Mills is a postdoctoral researcher with the Discipline of Addiction Medicine, University of Sydney and South-Eastern Sydney Local Health District. His interests are cannabis dependence in a clinical and medicinal context, and in using routinely-collected clinical drug and alcohol data to improve drug and alcohol treatment.
Dr Amelia Woods
Phd Student, Addiction Medicine Registrar, Gp
NDARC/DASSA

XR-BUP in prison: A report on qualitative data from patients commenced on treatment during a clinical trial

2:05 PM - 2:10 PM

Biography

Amelia is 2nd year PhD Candidate and Medical Doctor based at Drug and Alcohol Services SA. She completed a Masters of Addictive Behaviours and has held roles supporting registrars in conducting research. In her clinical roles, she has worked as a GP in Aboriginal and Prison Health Services
Dr Alison Seccull
Research Fellow
UNSW

‘Just like any other patient’: Client and health provider perceptions following transfer of opioid agonist treatment clients to primary care

2:10 PM - 2:20 PM

Biography

Alison is a regional doctor with a variety of roles. Her clinical work spans primary care as well as the hospital system with roles in opioid substitution therapy and women’s health. She is also a Senior Lecturer at the UNSW Rural Clinical School and the National Drug and Alcohol Centre (NDARC).
Ms Jie Yang
PhD Candidate
Monash University

Associations between pain severity and opioid agonist treatment using the SuperMIX cohort data in Australia

2:20 PM - 2:25 PM

Biography

Jie (Jenna) Yang is a third-year PhD candidate from Monash University. Jenna has been awarded a Monash University-China Scholarship Council (CSC) Joint Scholarship. Her PhD is looking at the prevalence and correlates of pain among people with opioid use disorder to provide insights into optimal clinical management.
Mr Richard Armour
Phd Candidate & Critical Care Paramedic
Monash University & Ambulance Victoria

Initiation of opioid agonist therapy using buprenorphine in the emergency department or emergency out of hospital setting: a mixed-methods systematic review

2:25 PM - 2:30 PM

Biography

Richard Armour is a critical care paramedic with experience in Australia, the U.K, and Canada. As the Paramedic Practice Leader for Harm Reduction & Substance Use in British Columbia, he developed a passion for improving the care paramedics provide to people who use drugs.
APSAD 2024

Session Q&A

2:30 PM - 2:40 PM

Biography


Chair

Agenda Item Image
Katherine Senior
Addiction Medicine Specialist
DASSA

loading